|
|
|
Volumn 56 Suppl A, Issue , 2003, Pages 38-
|
|
Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
ADULT;
ARTICLE;
BRONCHIOLITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DOUBLE BLIND PROCEDURE;
HUMAN;
MALE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VITAL CAPACITY;
ADULT;
ANTI-BACTERIAL AGENTS;
AZITHROMYCIN;
BIOLOGICAL MARKERS;
BRONCHIOLITIS;
C-REACTIVE PROTEIN;
CYSTIC FIBROSIS;
DOUBLE-BLIND METHOD;
HUMANS;
MALE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
VITAL CAPACITY;
|
|
EID: 1542499217
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
